产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 1710138 | LTURM-34 | 1879887-96-3 | >98% |  |
| LTURM-34是一种新的有效的和选择性的DNA-PK抑制剂，可减轻体外对多 | ||||
| 1710137 | LY2606368 dihydrochloride | 1234015-54-3 | >98% |  |
| Prexasertib (LY2606368)是一个与ATP竞争的CHK1抑制剂带Ki值0.9 nmol/L。对于 | ||||
| 179301 | LDC1267 | 1361030-48-9 | >98% |  |
| LDC1267显著降低小鼠乳腺癌和黑色素瘤转移依赖NK细胞。TAM酪氨酸激 | ||||
| 1791119 | N-(2,5-二羟基苄基)-5-氨基水杨酸 | 125697-93-0 | 98.0% |  |
| Lavendustin C，也被称为HDBA和NSC 666251，是一种有效的表皮生长因子（ | ||||
| 52025 | 乐伐替尼(E7080) | 417716-92-8 | 98% | -cas-417716-92-8.png) |
| 乐伐替尼，又名E7080，是一种合成的、可口服的血管内皮生长因子 | ||||
| 1781108 | LXS-196 | 1874276-76-2 | 98.0% |  |
| <span style="color:#34495E;font-family:"font-size:14px;background-color: | ||||
| 178902 | LDC4297(LDC044297) | 1453834-21-3 | 98.0% | -cas-1453834-21-3.png) |
| LDC4297也称为LCD044297,是一种有效、具有选择性的CDK7抑制剂。 | ||||
| 2017887 | LY3214996 | 1951483-29-6 | 98.0% |  |
| LY-3214996是一种有效且具有选择性的，可用于口服的细胞外信号的 | ||||
| 20178218 | LTX-315 | 1345407-05-7 | 98% |  |
| LTX-315是一种两性分子的阳离子肽可能用于治疗黑色素瘤、乳腺癌 | ||||
| 20178212 | LY 344864 | 186544-26-3 | 98.0% |  |
| LY344864是一种选择性5-HT1F受体激动剂，在最近克隆的5 - HT1F受体上 | ||||
| 2017828 | 盐酸LY 344864 | 1217756-94-9 | 98.0% |  |
| LY344864 hydrochloride is a potent and selective 5-HT1F receptor agonist. It has an E | ||||
| 17030102 | Lys05 trihydrochloride | 1391426-24-6 | 98% | |
| Lys05, 或Lys01三盐酸化物，是一种有效的水溶性溶酶体自噬抑制剂。 | ||||
| 17022807 | 拉帕替尼 | 231277-92-2 | 98% |  |
| 拉帕替尼(GW-572016) 是一种有效的EGFR和ErbB2抑制剂，IC50分别为10.8和 | ||||
| 17022706 | 雷西那德 | 878672-00-5 | 98% |  |
| 雷西那德(RDEA594),是URAT1的一日一次抑制剂，是肾脏中调节尿酸排泄 | ||||
| 17021601 | LY3039478 ( Crenigacestat ) | 1421438-81-4 | ≧98.0% |  |
| LY3039478 ( Crenigacestat ) 是一种选择性 NOTCH1 抑制剂，通过阻断 VEGFA/ | ||||
| 17021314 | LCI699 | 928134-65-0 | 98% | |
| LCI699(Osilodrostat)是一种强有力的抑制剂11β-羟化酶,酶催化合成皮质 | ||||
| 17012102 | lumateperone(Tosylate) | 1187020-80-9 | 98% | _1187020-80-9.png) |
| Lumateperone (ITI-722/ITI-007)是一种新型的双5HT2A受体拮抗剂/多巴胺磷蛋 | ||||
| 16123043 | Lys05 | 1391426-22-4 | 98% |  |
| Lys05 is a potent lysosomal autophagy inhibitor. Lys05 is a previously undescribed di | ||||
| 16123042 | LY-3177833 | 1627696-51-8 | 98% | |
| LY-3177833 is a potent and selective inhibitor of CDC7 (Cell Division Cycle 7-related | ||||
| 16123041 | LY3009120 | 1454682-72-4 | 98% | |
| LY3009120, also known as DP-4978, is potent and selective pan-RAF inhibitor with pote | ||||
| 16123040 | LY2334737 | 892128-60-8 | 98% | |
| LY2334737 is an orally available valproic acid ester of gemcitabine, a broad-spectrum | ||||
| 16123039 | LY2109761 | 700874-71-1 | 98% |  |
| LY2109761 is a novel transforming growth factor beta receptor type I and type II dual | ||||
| 16123038 | Luliconazole | 187164-19-8 | 98% |  |
| Luliconazole is an azole antifungal drug. As a 1% topical cream, luliconazole is indi | ||||
| 16123037 | Lubiprostone | 333963-40-9 | 98% |  |
| Lubiprostone, also known as RU-0211, is a medication used in the management of chroni | ||||
| 16123036 | LOXO-101 (ARRY-470) | 1223403-58-4 | 98% | -cas-1223403-58-4.png) |
| Larotrectinib, also known as ARRY-470 and LOXO-101, is an orally bioavailable, potent | ||||
| 16123035 | Lomitapide free base | 182431-12-5 | 98% |  |
| Lomitapide is a MTP inhibitor. Lomitapid is a novel agent for the treatment of homozy | ||||
| 16123034 | Lometrexol disodium | 106400-81-1 | 98% |  |
| Lometrexol is a folate analog antimetabolite with antineoplastic activity. As the 6R | ||||
| 16123033 | LGK974 (WNT974) | 1243244-14-5 | 98% | -cas-1243244-14-5.png) |
| LGK974, aslo known as is a selective and orally bioavailable Porcupine (PORCN) inhibi | ||||
| 16123031 | Levobupivacaine free base | 27262-47-1 | 98% |  |
| Levobupivacaine is a local anaesthetic drug belonging to the amino amide group. It is | ||||
| 16122828 | L67 | 325970-71-6 | 98% | |
| L67 is a DNA Ligase Inhibitor. L67 inhibited DNA ligases I and III. L67 is a simple c | ||||